cannabis indica

Sistema Respiratório

termo de indexação original: Respiratory System

O acervo do Cannabis Indica reúne 261 estudos científicos que tocam o Sistema Respiratório, publicados entre 1960 e 2024. Pela leitura automatizada, 170 (65%) foram classificados como favoráveis, 41 (16%) como inconclusivos e 50 (19%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (124 estudos), seguido de estudo laboratorial (59). As condições mais estudadas dentro deste sistema são COVID-19, Inflamação e Câncer.

Estudos indexados
261
Período coberto
1960–2024
Favoráveis
170 · 65%
Inconclusivos
41 · 16%
Desfavoráveis
50 · 19%
Termo original
Respiratory System

O acervo em números

Tipo de estudo

Metanálise124
Estudo Laboratorial59
Estudo em Animais44
Ensaio Clínico Duplo-Cego18
Ensaio Clínico16

Direção do resultado

Favorável170
Inconclusivo41
Desfavorável50

Por década

1960s1
1970s10
1980s3
1990s2
2000s15
2010s58
2020s172

261 estudos

Filtrar e buscar no acervo →
  1. 2024

    A Single-Blind, Randomized, Placebo Controlled Study to Evaluate the Benefits and Safety of Endourage Targeted Wellness Formula C Sublingual +Drops in People with Post-Acute Coronavirus Disease 2019 Syndrome

    FavorávelEnsaio ClínicoCOVID-19Ômega-3Ômega-6
  2. 2024

    Chemical compounds, anti-tumor and anti-neuropathic pain effect of hemp essential oil in vivo

    FavorávelEstudo em AnimaisDorCâncerInflamação+2
  3. 2024

    Clinical factors associated with smoking cessation among smokers with Chronic Obstructive Pulmonary Disease by sex: Longitudinal analyses from French smoking cessation services

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — NicotinaDPOC
  4. 2024

    Palmitoylethanolamide and Luteolin for postinfectious olfactory disorders: How clinically meaningful is its effect?

  5. 2023

    Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABAB-ergic activity and cortical plasticity in long COVID-19 syndrome

  6. 2023

    E-cigarette or vaping-associated lung injury (EVALI): a review of international case reports from outside the United States of America

  7. 2023

    Effect of any form of steroids in comparison with that of other medications on the duration of olfactory dysfunction in patients with COVID-19: A systematic review of randomized trials and quasi-experimental studies

    FavorávelMetanáliseInflamaçãoDepressãoCOVID-19Palmitoiletanolamida (PEA)
  8. 2023

    Mental health and substance use screening in HIV primary care before and during the early COVID-19 pandemic

    InconclusivoMetanáliseDependência QuímicaDependência — CannabisAnsiedade+7
  9. 2023

    Moderating the impact of the COVID-19 pandemic on children's and adolescents' substance use, digital media use, and mental health: A randomized positive psychology addiction prevention program

    FavorávelEnsaio ClínicoDependência QuímicaCOVID-19
  10. 2023

    Parosmia COVID-19 Related Treated by a Combination of Olfactory Training and Ultramicronized PEA-LUT: A Prospective Randomized Controlled Trial

  11. 2023

    Scoping review of guidance on cessation interventions for electronic cigarettes and dual electronic and combustible cigarettes use

    DesfavorávelMetanáliseEfeitos Adversos da CannabisLesão Pulmonar por Vaping (EVALI)
  12. 2023

    Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial

    FavorávelEnsaio Clínico Duplo-CegoDoenças NeurodegenerativasCOVID-19Palmitoiletanolamida (PEA)
  13. 2023

    Young Adults' Perceptions of and Intentions to Use Nicotine and Cannabis Vaporizers in Response to e-Cigarette or Vaping-Associated Lung Injury Instagram Posts: Experimental Study

    FavorávelEnsaio ClínicoEfeitos Adversos da CannabisLesão Pulmonar por Vaping (EVALI)
  14. 2022

    [Inhaled marijuana and the lung, a toxic cocktail?]

    DesfavorávelMetanáliseCâncerEfeitos Adversos da CannabisDependência — Nicotina+2
  15. 2022

    Adolescent e-cigarette or vaping product use-associated lung injury: A case series and review of the literature

    DesfavorávelMetanáliseInflamaçãoDoenças Cardiovasculares (DCV)Hipertensão Arterial+4
  16. 2022

    Agathis robusta Bark Essential Oil Effectiveness against COVID-19: Chemical Composition, In Silico and In Vitro Approaches

    FavorávelEstudo LaboratorialCOVID-19
  17. 2022

    Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection

  18. 2022

    Candidate Psychotropics against SARS - CoV - 2: A Narrative Review

    FavorávelMetanáliseCOVID-19
  19. 2022

    Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses

    FavorávelEstudo em AnimaisCOVID-19
  20. 2022

    Cannabidiol Regulates PPARγ-Dependent Vesicle Formation as well as Cell Death in A549 Human Lung Cancer Cells

    FavorávelEstudo LaboratorialCâncerCâncer — Pulmão
  21. 2022

    Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence

  22. 2022

    Cannabinoid receptor 2 engagement promotes group 2 innate lymphoid cell expansion and enhances airway hyperreactivity

    FavorávelEstudo em AnimaisInflamaçãoAsmaEndocanabinoide (não especificado)
  23. 2022

    Cannabinoids as Emergent Therapy Against COVID-19

    FavorávelMetanáliseInflamaçãoCOVID-19Estresse+1
  24. 2022

    Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants

    FavorávelEstudo LaboratorialCOVID-19Ácido Canabidiólico (CBD-a)Ácido Canabigerólico (CBG-a)
  25. 2022

    Cannabinoids receptors in Covid-19: Perpetrators and victims

  26. 2022

    Cannabis consumption is associated with lower COVID-19 severity among hospitalized patients: a retrospective cohort analysis

    FavorávelMetanáliseInflamaçãoCOVID-19Tetraidrocanabinol (THC)
  27. 2022

    Cannabis use and risks of respiratory and all-cause morbidity and mortality: a population-based, data-linkage, cohort study

  28. 2022

    Cannabis Vaping Among Youth and Young Adults: a Scoping Review

    DesfavorávelMetanáliseLesão Pulmonar por Vaping (EVALI)
  29. 2022

    Cannabis vaping: existing and emerging modalities, chemistry, and pulmonary toxicology

  30. 2022

    Chemical Analysis by LC-MS of Cannabis sativa Root Samples from Northeast Brazil and Evaluation of Antitussive and Expectorant Activities

    FavorávelEstudo em AnimaisTosseTetraidrocanabinol (THC)
  31. 2022

    Concurrent use of e-cigarettes and cannabis and associated COVID-19 symptoms, testing, and diagnosis among student e-cigarette users at four U.S. Universities

    DesfavorávelMetanáliseCOVID-19
  32. 2022

    Could Palmitoylethanolamide Be an Effective Treatment for Long-COVID-19? Hypothesis and Insights in Potential Mechanisms of Action and Clinical Applications

  33. 2022

    E-cigarette vaping associated acute lung injury (EVALI): state of science and future research needs

    DesfavorávelMetanáliseCâncerAnsiedadeDoenças Cardiovasculares (DCV)+17
  34. 2022

    Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene responses to the SARS-CoV-2 genes ORF8, ORF10 and M protein

    FavorávelEstudo LaboratorialCOVID-19
  35. 2022

    Effect of Ultra-Micronized Palmitoylethanolamide and Luteolin on Olfaction and Memory in Patients with Long COVID: Results of a Longitudinal Study

    FavorávelEnsaio ClínicoInflamaçãoCOVID-19Anandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  36. 2022

    Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19

  37. 2022

    Endocannabinoid metabolism inhibition ameliorates ovalbumin-induced allergic airway inflammation and hyperreactivity in Guinea pigs

  38. 2022

    Endocannabinoid signalling/cannabinoid receptor 2 is involved in icariin-mediated protective effects against bleomycin-induced pulmonary fibrosis

    FavorávelEstudo em AnimaisFibroseDPOCFibrose — PulmonarEndocanabinoide (não especificado)
  39. 2022

    Endothelial dysfunction and angiogenesis: what is missing from COVID-19 and cannabidiol story?

  40. 2022

    Expression and Functions of the CB 2 Receptor in Human Leukocytes

  41. 2022

    In Vitro Effect of Δ9-Tetrahydrocannabinol and Cannabidiol on Cancer-Associated Fibroblasts Isolated from Lung Cancer

    FavorávelEstudo LaboratorialCâncerCâncer — Pulmão
  42. 2022

    Inhaled Marijuana and the Lung

    InconclusivoMetanáliseAsmaLesão Pulmonar por Vaping (EVALI)Bronquite
  43. 2022

    Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic

    FavorávelEnsaio ClínicoAnsiedadeCOVID-19
  44. 2022

    Medicinal Herbs in the Relief of Neurological, Cardiovascular, and Respiratory Symptoms after COVID-19 Infection A Literature Review

  45. 2022

    Nationwide Trends in Hospitalizations and Outcomes of Pulmonary Circulation Disorders Among Patients With Cannabis Use Disorder in the United States

    DesfavorávelMetanáliseDependência QuímicaInflamaçãoEfeitos Adversos da Cannabis+9
  46. 2022

    Over 1 year later: smokers' EVALI awareness, knowledge and perceived impact on e-cigarette interest

    DesfavorávelMetanáliseEfeitos Adversos da CannabisLesão Pulmonar por Vaping (EVALI)
  47. 2022

    Palmitoylethanolamide Reduces Proinflammatory Markers in Unvaccinated Adults Recently Diagnosed with COVID-19: A Randomized Controlled Trial

  48. 2022

    Prevalence of Adolescent Cannabis Vaping: A Systematic Review and Meta-analysis of US and Canadian Studies

    DesfavorávelMetanáliseLesão Pulmonar por Vaping (EVALI)
  49. 2022

    Substance Use Among Youth During the COVID-19 Pandemic: a Systematic Review

  50. 2022

    The endocannabinoid anandamide is an airway relaxant in health and disease

    FavorávelEstudo em AnimaisAsmaDPOCAnandamida (AEA)
  51. 2022

    The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury

    InconclusivoMetanáliseLesão Pulmonar por Vaping (EVALI)
  52. 2022

    Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled Clinical Trial

    FavorávelEnsaio Clínico Duplo-CegoInflamaçãoCOVID-19Palmitoiletanolamida (PEA)
  53. 2021

    [Electronic cigarette use-associated lung injury: a case report and literature review]

    DesfavorávelMetanáliseEfeitos Adversos da CannabisLesão Pulmonar por Vaping (EVALI)
  54. 2021

    A 20-Year-Old Man with e-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and Thrombotic Coagulopathy

    DesfavorávelMetanáliseLesão Pulmonar por Vaping (EVALI)
  55. 2021

    A 23-year-old man with acute lung injury after using a tetrahydrocannabinol-containing vaping device: a case report

    DesfavorávelMetanáliseInflamaçãoEfeitos Adversos da CannabisNáusea e Vômito+6
  56. 2021

    A clinician survey of use assessment, documentation, and education about cannabis in persons with cystic fibrosis

    InconclusivoMetanáliseFibroseFibrose — Pulmonar
  57. 2021

    A potential role for cannabichromene in modulating TRP channels during acute respiratory distress syndrome

  58. 2021

    A randomized controlled trial of a therapeutic relational agent for reducing substance misuse during the COVID-19 pandemic

    FavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisAnsiedade+3
  59. 2021

    A Rare Case of Vaping-Induced Spontaneous Pneumomediastinum

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)+4
  60. 2021

    A secondary approach with conventional medicines and supplements to recuperate current COVID-19 status

    FavorávelMetanáliseCOVID-19
  61. 2021

    ACPA decreases non-small cell lung cancer line growth through Akt/PI3K and JNK pathways in vitro

  62. 2021

    Activity of (-)-Camphene Derivatives Against Mycobacterium tuberculosis in Acidic pH

    FavorávelEstudo LaboratorialTuberculose
  63. 2021

    Acute lung injury-from cannabis to COVID

    InconclusivoMetanáliseInflamaçãoEfeitos Adversos da CannabisCOVID-19+5
  64. 2021

    Adolescent Cannabis Hyperemesis Syndrome During the COVID-19 Pandemic

  65. 2021

    Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review

    FavorávelMetanáliseCOVID-19
  66. 2021

    Appropriate use of essential oils and their components in the management of upper respiratory tract symptoms in patients with COVID-19

    FavorávelMetanáliseCOVID-19
  67. 2021

    Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches

    FavorávelEstudo LaboratorialCOVID-19
  68. 2021

    Borneol inhibits CD4 + T cells proliferation by down-regulating miR-26a and miR-142-3p to attenuate asthma

    FavorávelEstudo em AnimaisInflamaçãoAsma
  69. 2021

    Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019

  70. 2021

    Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19?

    FavorávelMetanáliseCOVID-19
  71. 2021

    Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic

  72. 2021

    Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    InconclusivoEnsaio Clínico Duplo-CegoCOVID-19
  73. 2021

    Cannabidiol Inhibits In Vitro Human Liver Microsomal Metabolism of Remdesivir: A Promising Adjuvant for COVID-19 Treatment

    FavorávelEstudo LaboratorialCOVID-19
  74. 2021

    Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response

    FavorávelEstudo LaboratorialCâncerInflamaçãoCOVID-19Canabigerol (CBG)Canabicromeno (CBC)+2
  75. 2021

    Cannabidiol inhibits SARS-Cov-2 spike (S) protein-induced cytotoxicity and inflammation through a PPARγ-dependent TLR4/NLRP3/Caspase-1 signaling suppression in Caco-2 cell line

    FavorávelEstudo LaboratorialCOVID-19
  76. 2021

    Cannabinoids for SARS-CoV-2 and is there evidence of their therapeutic efficacy?

    FavorávelMetanáliseCOVID-19
  77. 2021

    Cannabis attitudes and patterns of use among followers of the Allergy & Asthma Network

    FavorávelMetanáliseAsma
  78. 2021

    Cannabis compounds exhibit anti-inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages

    InconclusivoEstudo LaboratorialInflamaçãoCOVID-19Canabigerol (CBG)Tetraidrocanabivarina (THCV)
  79. 2021

    Cannabis-Induced Mania Following COVID-19 Self-Medication: A Wake-Up Call to Improve Community Awareness

    DesfavorávelMetanáliseEfeitos Adversos da CannabisPsicoseCOVID-19+1
  80. 2021

    Cannabis/Cannabinoids for Treating COVID-19 Associated Neuropsychiatric Complications

    InconclusivoMetanáliseDependência — CannabisAnsiedadeDepressão+3
  81. 2021

    Case of e-cigarette or vaping product use-associated lung injury (EVALI) in London, UK

    DesfavorávelMetanáliseLesão Pulmonar por Vaping (EVALI)
  82. 2021

    CB1R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky–Pudlak syndrome

  83. 2021

    Chemical Emissions From Heated Vitamin E Acetate—Insights to Respiratory Risks From Electronic Cigarette Liquid Oil Diluents Used in the Aerosolization of Δ9-THC-Containing Products

  84. 2021

    Chemopreventive potential of linalool in targeting lung cancer biomarkers: An in silico & in vitro investigation

    FavorávelEstudo LaboratorialCâncerCâncer — Pulmão
  85. 2021

    Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders?

    FavorávelMetanáliseAnsiedadeDepressãoInsônia e Distúrbios do Sono+2
  86. 2021

    COVID-19 and Cannabis: Playing Saint or Devil?

  87. 2021

    D-Limonene Is a Potential Monoterpene to Inhibit PI3K/Akt/IKK-α/NF-κB p65 Signaling Pathway in Coronavirus Disease 2019 Pulmonary Fibrosis

    FavorávelEstudo em AnimaisCOVID-19FibroseFibrose — Pulmonar
  88. 2021

    E-Cigarette or Vaping Associated Lung Injury: Evolving Threat to Healthy Teens

    DesfavorávelMetanáliseEfeitos Adversos da CannabisLesão Pulmonar por Vaping (EVALI)
  89. 2021

    Effect of COVID-19 Pandemic on Cannabis Use in Cancer Patients

    InconclusivoMetanáliseCâncerCOVID-19
  90. 2021

    Electrochemical sensing: A prognostic tool in the fight against COVID-19

    FavorávelMetanáliseInflamaçãoCOVID-19
  91. 2021

    Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis

  92. 2021

    Essential oils as an effective alternative for the treatment of COVID-19: Molecular interaction analysis of protease (Mpro) with pharmacokinetics and toxicological properties

    FavorávelEstudo LaboratorialCOVID-19
  93. 2021

    EVALI - E-Cigarette or Vaping Product Use-Associated Lung Injury: A Case Report

  94. 2021

    Fighting the storm: could novel anti-TNFα and anti-IL-6 C. sativa cultivars tame cytokine storm in COVID-19?

    InconclusivoEstudo LaboratorialCOVID-19Canabigerol (CBG)Canabinol (CBN)+2
  95. 2021

    Genetic Liability to Cannabis Use Disorder and COVID-19 Hospitalization

  96. 2021

    Geraniol exerts its antiproliferative action by modulating molecular targets in lung and skin carcinoma cells

    FavorávelEstudo LaboratorialCâncerCâncer — PulmãoCâncer — Melanoma+1
  97. 2021

    High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients

  98. 2021

    In quest of a new therapeutic approach in COVID-19: the endocannabinoid system

    FavorávelMetanáliseCOVID-19
  99. 2021

    In silico identification of compounds from Nigella sativa seed oil as potential inhibitors of SARS-CoV-2 targets

    FavorávelEstudo LaboratorialCOVID-19
  100. 2021

    In silico inquest reveals the efficacy of Cannabis in the treatment of post-Covid-19 related neurodegeneration

    FavorávelEstudo LaboratorialCOVID-19
  101. 2021

    In Vitro Evaluation of the Activity of Terpenes and Cannabidiol against Human Coronavirus E229

    FavorávelEstudo LaboratorialCOVID-19
  102. 2021

    Insulin Receptor Substrate 1 Is Involved in the Phycocyanin-Mediated Antineoplastic Function of Non-Small Cell Lung Cancer Cells

    FavorávelEstudo LaboratorialCâncerCâncer — PulmãoFicocianina
  103. 2021

    Investigation of antinociceptive, antipyretic, antiasthmatic, and spasmolytic activities of Brazilian Cannabis sativa L. roots in rodents

    FavorávelEstudo em AnimaisDorInflamaçãoDor — Aguda+1
  104. 2021

    Less COVID-19 deaths in southern and insular Italy explained by forest bathing, Mediterranean environment, and antiviral plant volatile organic compounds

    FavorávelMetanáliseCOVID-19
  105. 2021

    Lung cancer patient who had declined conventional cancer treatment: could the self-administration of ‘CBD oil’ be contributing to the observed tumour regression?

    FavorávelMetanáliseCâncerCâncer — Pulmão
  106. 2021

    Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach

    FavorávelEstudo em AnimaisInflamaçãoCOVID-19EstressePalmitoiletanolamida (PEA)+1
  107. 2021

    Mechanism deconvolution of Qing Fei Pai Du decoction for treatment of Coronavirus Disease 2019 (COVID-19) by label-free integrative pharmacology assays

    FavorávelEstudo LaboratorialCOVID-19
  108. 2021

    Micronized / ultramicronized palmitoylethanolamide (PEA) as natural neuroprotector against COVID-19 inflammation

    FavorávelMetanáliseInflamaçãoCOVID-19Palmitoiletanolamida (PEA)
  109. 2021

    Morbidity and mortality associated with prescription cannabinoid drug use in COPD

    DesfavorávelMetanáliseDPOC
  110. 2021

    Multiple clinical risks for cannabis users during the COVID-19 pandemic

    DesfavorávelMetanáliseCOVID-19
  111. 2021

    Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19

    FavorávelMetanáliseCOVID-19
  112. 2021

    Quaternary ammonium salts based on (-)-borneol as effective inhibitors of influenza virus

    FavorávelEstudo LaboratorialGripe
  113. 2021

    Randomized clinical trial "olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin": preliminary results

    FavorávelEnsaio ClínicoCOVID-19Palmitoiletanolamida (PEA)
  114. 2021

    Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19: Docking and molecular dynamics simulation studies

    FavorávelEstudo LaboratorialCOVID-19
  115. 2021

    Surveillance of work-related asthma including the emergence of a cannabis-associated case series in Washington State

    FavorávelMetanáliseEfeitos Adversos da CannabisAsma
  116. 2021

    Targeting of Protein's Messenger RNA for Viral Replication, Assembly and Release in SARS-CoV-2 Using Whole Genomic Data From South Africa: Therapeutic Potentials of Cannabis Sativa L

    FavorávelEstudo LaboratorialCOVID-19
  117. 2021

    THC Exposure is Reflected in the Microstructure of the Cerebral Cortex and Amygdala of Young Adults

    InconclusivoEnsaio ClínicoDisfunção CognitivaDPOC
  118. 2021

    The Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome by Downregulating miRNA that Target Inflammatory Pathways

  119. 2021

    The Immunopathology of COVID-19 and the Cannabis Paradigm

    InconclusivoMetanáliseCOVID-19
  120. 2021

    The Monoacylglycerol Lipase Inhibitor JZL184 Inhibits Lung Cancer Cell Invasion and Metastasis via the CB 1 Cannabinoid Receptor

  121. 2021

    The potential of cannabinoids and inhibitors of endocannabinoid degradation in respiratory diseases

    FavorávelMetanáliseCâncerCOVID-19Câncer — Pulmão+3
  122. 2021

    The pro-apoptosis effects of Echinacea purpurea and Cannabis sativa extracts in human lung cancer cells through caspase-dependent pathway

    FavorávelEstudo LaboratorialCâncerCâncer — PulmãoCanabinoides Sintéticos AM-xEquinácea
  123. 2021

    Trends in Prevalence and Outcomes of Cannabis Use Among Chronic Obstructive Pulmonary Disease Hospitalizations: A Nationwide Population-Based Study 2005-2014

    FavorávelMetanáliseDPOC
  124. 2021

    Unsubstantiated health claims for COVID-19 infections are led by cannabidiol: return of snake oil medicine

    InconclusivoMetanáliseCOVID-19
  125. 2021

    Vape-Associated Pulmonary Injury (VAPI) Presenting With a "Miliary" Pattern on Imaging

    DesfavorávelMetanáliseInflamaçãoEfeitos Adversos da CannabisNáusea e Vômito+4
  126. 2021

    Vaping Cannabis Butane Hash Oil Leads to Severe Acute Respiratory Distress Syndrome-A Case of EVALI in a Teenager With Hypertrophic Cardiomyopathy

    DesfavorávelMetanáliseEstresseSíndrome do Desconforto Respiratório Agudo
  127. 2021

    What cannabis can learn from Covid: Hydroxychloroquine research suggests the next step for medical cannabis research

    InconclusivoMetanáliseCOVID-19
  128. 2021

    WIN 55,212-2 shows anti-inflammatory and survival properties in human iPSC-derived cardiomyocytes infected with SARS-CoV-2

    FavorávelEstudo LaboratorialCOVID-19Canabinoides Sintéticos WIN-x
  129. 2021

    β-Caryophyllene from Chilli Pepper Inhibits the Proliferation of Non-Small Cell Lung Cancer Cells by Affecting miR-659-3p-Targeted Sphingosine Kinase 1 (SphK1)

    FavorávelEstudo LaboratorialCâncerCâncer — Pulmão
  130. 2021

    β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19

    InconclusivoMetanáliseInflamaçãoDoenças Cardiovasculares (DCV)Disfunção Cognitiva+8
  131. 2020

    19-Year-Old Man With Fevers, Abdominal Pain, and Cough

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisNáusea e Vômito+3
  132. 2020

    A Case of Vaping TCH Oil Leading to Vaping Associated Pulmonary Injury: Our Approach to Its Diagnosis, Management, and Recommendations

    DesfavorávelMetanáliseLesão Pulmonar por Vaping (EVALI)
  133. 2020

    A Case Series of Vaping-Induced Lung Injury in a Community Hospital Setting

    DesfavorávelMetanáliseDependência — NicotinaLesão Pulmonar por Vaping (EVALI)
  134. 2020

    Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?

    InconclusivoMetanáliseCOVID-19
  135. 2020

    Administration of Δ9-Tetrahydrocannabinol (THC) Post-Staphylococcal Enterotoxin B Exposure Protects Mice From Acute Respiratory Distress Syndrome and Toxicity

    FavorávelEstudo em AnimaisEstresseSíndrome do Desconforto Respiratório Agudo
  136. 2020

    Analysis of Cannabinoid-Containing Fluids in Illicit Vaping Cartridges Recovered from Pulmonary Injury Patients: Identification of Vitamin E Acetate as a Major Diluent

    DesfavorávelMetanáliseLesão Pulmonar por Vaping (EVALI)
  137. 2020

    Can Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity?

    InconclusivoMetanáliseCOVID-19
  138. 2020

    Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA

    FavorávelEstudo em AnimaisCOVID-19
  139. 2020

    Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro

    FavorávelEstudo LaboratorialCâncerCâncer — Pulmão
  140. 2020

    Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?

    FavorávelMetanáliseCOVID-19
  141. 2020

    Cannabinoids and the Coronavirus

    InconclusivoMetanáliseCOVID-19
  142. 2020

    Cannabis for COVID-19: can cannabinoids quell the cytokine storm?

    FavorávelMetanáliseCOVID-19
  143. 2020

    Cannabis Vaping-Induced Acute Pulmonary Toxicity: Case Series and Review of Literature.

    FavorávelMetanáliseLesão Pulmonar por Vaping (EVALI)
  144. 2020

    CB2 receptor-selective agonists as candidates for targeting infection, inflammation, and immunity in SARS-CoV-2 infections

    FavorávelMetanáliseCOVID-19
  145. 2020

    Challenges at the Time of COVID-19: Opportunities and Innovations in Antivirals from Nature

    FavorávelMetanáliseCOVID-19Equinácea
  146. 2020

    Chemical Constituents Involved in E-Cigarette, or Vaping Product Use-Associated Lung Injury (EVALI)

    DesfavorávelMetanáliseLesão Pulmonar por Vaping (EVALI)Tetraidrocanabinol (THC)
  147. 2020

    Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine

    InconclusivoMetanáliseCOVID-19
  148. 2020

    COVID-19 and Cannabidiol (CBD)

    InconclusivoMetanáliseCOVID-19
  149. 2020

    Debunking Cannabidiol as a Treatment for COVID-19: Time for the FDA to Adopt a Focused Deterrence Model?

    DesfavorávelMetanáliseCâncerDepressãoDoença de Alzheimer+2
  150. 2020

    Do Not Huff, Puff, or Vape That Stuff: Interstitial Airspace Disease in a Teenager

    DesfavorávelMetanáliseDorInflamaçãoEfeitos Adversos da Cannabis+7
  151. 2020

    E-cigarette or vaping product use-associated lung injury and state-level cannabis policies

    InconclusivoMetanáliseLesão Pulmonar por Vaping (EVALI)
  152. 2020

    Engineering EHD1-Targeted Natural Borneol Nanoemulsion Potentiates Therapeutic Efficacy of Gefitinib against Nonsmall Lung Cancer

    FavorávelEstudo LaboratorialCâncerCâncer — Pulmão
  153. 2020

    Eucalyptol (1,8 cineole) from eucalyptus essential oil a potential inhibitor of COVID 19 corona virus infection by Molecular docking studies

    FavorávelEstudo LaboratorialCOVID-19
  154. 2020

    Evaluation of the Inhibitory Activities of COVID‐19 of Melaleuca cajuputi Oil Using Docking Simulation

    FavorávelEstudo LaboratorialCOVID-19
  155. 2020

    Genetic Liability to Cannabis Use Disorder and COVID-19 Hospitalization

    DesfavorávelMetanáliseCOVID-19
  156. 2020

    Geranium and Lemon Essential Oils and Their Active Compounds Downregulate Angiotensin-Converting Enzyme 2 (ACE2), a SARS-CoV-2 Spike Receptor-Binding Domain, in Epithelial Cells

    FavorávelEstudo LaboratorialCOVID-19
  157. 2020

    In Search of Preventative Strategies: Novel Anti-Inflammatory High-CBD Cannabis Sativa Extracts Modulate ACE2 Expression in COVID-19 Gateway Tissues

    FavorávelEstudo LaboratorialCOVID-19
  158. 2020

    In search of preventive strategies: novel high-CBD Cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissues

    InconclusivoEstudo LaboratorialCOVID-19
  159. 2020

    Letter to the Editor: Possible Drug–Drug Interactions Between Cannabinoids and Candidate COVID-19 Drugs

    InconclusivoMetanáliseCOVID-19
  160. 2020

    Limonene-induced activation of A 2A adenosine receptors reduces airway inflammation and reactivity in a mouse model of asthma

    FavorávelEstudo em AnimaisAsma
  161. 2020

    Medical Cannabis in Asthmatic Patients

    FavorávelMetanáliseAsmaBronquite
  162. 2020

    New Perspectives for Mucolytic, Anti-inflammatory and Adjunctive Therapy with 1,8-Cineole in COPD and Asthma: Review on the New Therapeutic Approach

    FavorávelMetanáliseAsmaDPOC
  163. 2020

    Opioids/cannabinoids as a potential therapeutic approach in COVID-19 patients

    InconclusivoMetanáliseCOVID-19
  164. 2020

    Protective effects of Δ 9 -tetrahydrocannabinol against enterotoxin-induced acute respiratory distress syndrome are mediated by modulation of microbiota

    FavorávelEstudo em AnimaisCOVID-19EstresseSíndrome do Desconforto Respiratório Agudo
  165. 2020

    Sedation challenges in patients with E-cigarette, or vaping, product use-associated lung injury (EVALI)

  166. 2020

    The potential of cannabidiol in the COVID-19 pandemic

    FavorávelMetanáliseCOVID-19
  167. 2020

    Therapeutic Cannabis and COVID-19: between opportunism and infoxication

    DesfavorávelMetanáliseCOVID-19
  168. 2020

    Therapeutic Efficacy of Cannabidiol (CBD): A Review of the Evidence from Clinical Trials and Human Laboratory Studies

    InconclusivoMetanáliseDorDependência QuímicaInflamação+7
  169. 2020

    Update: Characteristics of a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, August 2019-January 2020

    InconclusivoMetanáliseLesão Pulmonar por Vaping (EVALI)
  170. 2020

    Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019

    InconclusivoMetanáliseCOVID-19
  171. 2020

    Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI

    DesfavorávelMetanáliseLesão Pulmonar por Vaping (EVALI)
  172. 2020

    Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression

    FavorávelEstudo em AnimaisCOVID-19
  173. 2019

    A longitudinal study of cannabis use increasing the use of asthma medication in young Norwegian adults

    FavorávelMetanáliseAsma
  174. 2019

    Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies

    InconclusivoMetanáliseCâncerCâncer — PulmãoCâncer — Melanoma+1
  175. 2019

    Cannabis use and the risk of tuberculosis: a systematic review

    InconclusivoMetanáliseTuberculose
  176. 2019

    COPD secondary or associated with cannabis dependence

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDPOC
  177. 2019

    Dietary intake of fatty acids and its relationship with FEV1/FVC in patients with chronic obstructive pulmonary disease

    FavorávelMetanáliseInflamaçãoDPOCÁcido Pentadecanoico (C15:0)
  178. 2019

    Effects of Eucalyptol in respiratory system mechanics on acute lung injury after exposure to short-term cigarette smoke

  179. 2019

    Impact of changes in regular use of marijuana and/or tobacco on chronic bronchitis

    DesfavorávelMetanáliseBronquite
  180. 2019

    Phytol Ameliorated Benzo(a)pyrene Induced Lung Carcinogenesis in Swiss Albino Mice via Inhibition of Oxidative Stress and Apoptosis

    FavorávelEstudo em AnimaisCâncerEstresse OxidativoCâncer — Pulmão
  181. 2019

    Regular cannabis use, with and without tobacco co-use, is associated with respiratory disease

    DesfavorávelMetanáliseAsmaDPOC
  182. 2019

    Spicae aetheroleum in uncomplicated acute bronchitis: a double-blind, randomised clinical trial

    FavorávelEnsaio Clínico Duplo-CegoBronquite
  183. 2019

    Striking lung cancer response to self-administration of cannabidiol: A case report and literature review

    FavorávelMetanáliseCâncerCâncer — Pulmão
  184. 2019

    Synthesis and in vitro study of novel borneol derivatives as potent inhibitors of the influenza A virus

    FavorávelEstudo LaboratorialGripe
  185. 2019

    Synthesis of Novel (-)-Camphene-based Thiosemicarbazones and Evaluation of Anti- Mycobacterium tuberculosis Activity

    FavorávelEstudo LaboratorialTuberculose
  186. 2019

    Vitamin E Acetate as a Plausible Cause of Acute Vaping-related Illness

    DesfavorávelMetanáliseLesão Pulmonar por Vaping (EVALI)
  187. 2018

    Cannabis Use, Lung Cancer, and Related Issues

    FavorávelMetanáliseDorCâncerAnsiedadeTHC Farmacêutico+4
  188. 2018

    Discovery of a Novel Series of α-Terpineol Derivatives as Promising Anti-Asthmatic Agents: Their Design, Synthesis, and Biological Evaluation

    FavorávelEstudo em AnimaisAsma
  189. 2018

    Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise Endurance in Advanced Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial

    InconclusivoEnsaio Clínico Duplo-CegoDPOC
  190. 2018

    Effects of cannabinoid receptor type 2 in respiratory syncytial virus infection in human subjects and mice.

  191. 2018

    Endocannabinoid engagement of CB2 regulates RSV-induced immunity

  192. 2018

    Phytol Shows Anti-Angiogenic Activity and Induces Apoptosis in A549 Cells by Depolarizing the Mitochondrial Membrane Potential

    FavorávelEstudo LaboratorialCâncerCâncer — Pulmão
  193. 2018

    The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial

    FavorávelEnsaio Clínico Duplo-CegoDorInsônia e Distúrbios do SonoAnorexia (perda de apetite)THC Farmacêutico+5
  194. 2018

    The Role of Cannabinoid Receptor 1 in the Immunopathology of Respiratory Syncytial Virus.

  195. 2017

    Activation of cannabinoid receptor type 2 by JWH133 alleviates bleomycin-induced pulmonary fibrosis in mice

  196. 2017

    Cannabis and lung. What we know and everything we don't know yet.

    InconclusivoMetanáliseDPOC
  197. 2017

    Intranasal co-administration of 1,8-cineole with influenza vaccine provide cross-protection against influenza virus infection

    FavorávelEstudo em AnimaisGripe
  198. 2017

    Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids

    FavorávelMetanáliseCâncerCâncer — Pulmão
  199. 2017

    Phytol Induces ROS Mediated Apoptosis by Induction of Caspase 9 and 3 Through Activation of TRAIL, FAS and TNF Receptors and Inhibits Tumor Progression Factor Glucose 6 Phosphate Dehydrogenase in Lung Carcinoma Cell Line (A549)

    FavorávelEstudo LaboratorialCâncerCâncer — Pulmão
  200. 2017

    Suppression of inflammatory and infection responses in lung macrophages by eucalyptus oil and its constituent 1,8-cineole: Role of pattern recognition receptors TREM-1 and NLRP3, the MAP kinase regulator MKP-1, and NFκB

    FavorávelEstudo LaboratorialAsmaDPOCTosse
  201. 2017

    Targeting fatty acid amide hydrolase as a therapeutic strategy for antitussive therapy.

    FavorávelEstudo em AnimaisTosseAnandamida (AEA)Endocanabinoide (não especificado)+2
  202. 2016

    A Randomized Placebo Controlled Trial of Ibuprofen for Respiratory Syncytial Virus Infection in a Bovine Model

  203. 2016

    Effect of Treatment With Geraniol on Ovalbumin-Induced Allergic Asthma in Mice

    FavorávelEstudo em AnimaisAsma
  204. 2016

    The antitumor activity of plant-derived non-psychoactive cannabinoids

    FavorávelMetanáliseCâncerCâncer — Pulmão
  205. 2016

    The Effect Of Cannabinoids On Dinitrofluorobenzene-induced Experimental Asthma In Mice

    FavorávelEstudo em AnimaisAsmaCanabinoide Sintético (não especificado)
  206. 2016

    Ultramicronized palmitoylethanolamide (PEA-um(®)) in the treatment of idiopathic pulmonary fibrosis

    FavorávelEstudo em AnimaisInflamaçãoFibroseFibrose — PulmonarPalmitoiletanolamida (PEA)
  207. 2016

    Δ9-Tetrahydrocannabinol Reverses TNFα-induced Increase In Airway Epithelial Cell Permeability Through CB2 Receptors

    FavorávelEstudo LaboratorialAsmaTosseCanabinoides Sintéticos AM-xCanabinoides Sintéticos JWH-x
  208. 2015

    Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium

    DesfavorávelMetanáliseCâncerCâncer — Pulmão
  209. 2015

    Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma

    FavorávelEstudo em AnimaisAsma
  210. 2015

    Synergistic Antitumor Effect of α-Pinene and β-Pinene With Paclitaxel Against Non-Small-Cell Lung Carcinoma (NSCLC)

    FavorávelEstudo LaboratorialCâncerCâncer — Pulmão
  211. 2015

    The Effect of Phytocannabinoids on Airway Hyper-Responsiveness, Airway Inflammation, and Cough.

    FavorávelEstudo em AnimaisTosseTetraidrocanabinol (THC)Canabinoides Sintéticos AM-x+5
  212. 2014

    Anti-inflammatory Properties of the Monoterpene 1.8-cineole: Current Evidence for Co-Medication in Inflammatory Airway Diseases

    FavorávelMetanáliseAsmaDPOC
  213. 2014

    Cannabinoids Increase Lung Cancer Cell Lysis By Lymphokine-activated Killer Cells Via Upregulation Of ICAM-1

  214. 2013

    2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV.

  215. 2013

    Cannabis and the Lung: No More Smoking Gun?

    DesfavorávelMetanáliseCâncerCâncer — PulmãoDPOC
  216. 2013

    Cannabis use and impairment of respiratory function

    DesfavorávelMetanáliseBronquite
  217. 2013

    COX-2 And PPAR-γ Confer Cannabidiol-induced Apoptosis Of Human Lung Cancer Cells

    FavorávelEstudo LaboratorialCâncerCâncer — Pulmão
  218. 2013

    Efficacy of cineole in patients suffering from acute bronchitis: a placebo-controlled double-blind trial

    FavorávelEnsaio Clínico Duplo-CegoTosseBronquite
  219. 2013

    Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ(9)-tetrahydrocannabinol in the rat

  220. 2013

    Δ9-Tetrahydrocannabinol Impairs the Inflammatory Response to Influenza Infection: Role of Antigen-Presenting Cells and the Cannabinoid Receptors 1 and 2

    DesfavorávelEstudo em AnimaisGripeTetraidrocanabinol (THC)
  221. 2012

    Anti-proliferative and anti-angiogenic effects of CB2R agonist (JWH-133) in non-small lung cancer cells (A549) and human umbilical vein endothelial cells: an in vitro investigation

    FavorávelEstudo LaboratorialCâncerCâncer — PulmãoCanabinoides Sintéticos JWH-x
  222. 2012

    Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1

    FavorávelEstudo em AnimaisCâncerCâncer — PulmãoTetraidrocanabinol (THC)
  223. 2012

    Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis

  224. 2012

    Involvement of the endogenous cannabinoid 2 ligand 2-arachidonyl glycerol in allergic inflammation

    InconclusivoEstudo em AnimaisDermatite de Contato AlérgicaBronquite2-Araquidonoilglicerol (2-AG)
  225. 2012

    Patients with Asthma Benefit from Concomitant Therapy with Cineole: A Placebo-Controlled, Double-Blind Trial

    FavorávelEnsaio Clínico Duplo-CegoAsma
  226. 2011

    Activity of Melaleuca Alternifolia (Tea Tree) Oil on Influenza Virus A/PR/8: Study on the Mechanism of Action

    FavorávelEstudo LaboratorialGripe
  227. 2011

    Cannabinoid effects on ventilation and breathlessness: a pilot study of efficacy and safety.

    FavorávelEnsaio Clínico Duplo-CegoDPOCTetraidrocanabinol (THC)
  228. 2011

    Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection

    FavorávelEstudo em AnimaisGripe
  229. 2010

    Anti-inflammatory effects of limonene from yuzu (Citrus junos Tanaka) essential oil on eosinophils.

    FavorávelEstudo LaboratorialInflamaçãoAsma
  230. 2010

    Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells

    FavorávelEstudo LaboratorialCâncerCâncer — Pulmão
  231. 2009

    Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: a placebo-controlled double-blind trial

    FavorávelEnsaio Clínico Duplo-CegoDPOC
  232. 2009

    Effects of Marijuana Smoking on Pulmonary Function and Respiratory Complications: A Systematic Review.

    FavorávelMetanáliseAsmaTosseBronquite
  233. 2009

    Marijuana and chronic obstructive lung disease: a population-based study

    InconclusivoMetanáliseDPOCTosse
  234. 2009

    Preventive and therapeutic anti-inflammatory properties of the sesquiterpene α-humulene in experimental airways allergic inflammation

    FavorávelEstudo LaboratorialAsma
  235. 2008

    Delta9-Tetrahydrocannabinol Inhibits Epithelial Growth Factor-induced Lung Cancer Cell Migration In Vitro As Well As Its Growth And Metastasis In Vivo

    FavorávelEstudo LaboratorialCâncerCâncer — PulmãoTetraidrocanabinol (THC)
  236. 2008

    Targeted Deletion of Cannabinoid Receptors CB1 and CB2 Produced Enhanced Inflammatory Responses to Influenza A/PR/8/34 in the Absence and Presence of Delta9-tetrahydrocannabinol

    InconclusivoEstudo em AnimaisInflamaçãoGripe
  237. 2007

    Modulation of Airway Responses to Influenza A/PR/8/34 by 9-Tetrahydrocannabinol in C57BL/6 Mice

    DesfavorávelEstudo em AnimaisGripeTetraidrocanabinol (THC)
  238. 2006

    Inhaled marijuana smoke disrupts mitochondrial energetics in pulmonary epithelial cells in vivo

    DesfavorávelEstudo em AnimaisBronquite
  239. 2006

    Marijuana Use And The Risk Of Lung And Upper Aerodigestive Tract Cancers: Results Of A Population-based Case-control Study

    InconclusivoMetanáliseCâncerCâncer — Pulmão
  240. 2006

    Tuberculosis Outbreak in Marijuana Users, Seattle, Washington, 2004

    InconclusivoMetanáliseTuberculose
  241. 2005

    Cannabis and tobacco smoke are not equally carcinogenic

    InconclusivoMetanáliseCâncerCâncer — Pulmão
  242. 2005

    Dronabinol, a possible new therapeutic option in patients with COPD and pulmonal cachexia

    FavorávelEnsaio ClínicoAnorexia (perda de apetite)CaquexiaPerda de Apetite+1
  243. 2005

    Novel treatment for cough

  244. 2003

    Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial

    FavorávelEnsaio Clínico Duplo-CegoAsma
  245. 2003

    Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation.

    FavorávelEstudo em AnimaisTosseCanabinoides Sintéticos SR-xCanabinoides Sintéticos JWH-x
  246. 1998

    Inhibition of cytokine production and arachidonic acid metabolism by eucalyptol (1.8-cineole) in human blood monocytes in vitro.

    FavorávelEstudo LaboratorialCOVID-19AsmaTosse
  247. 1990

    Uptake, distribution and elimination of alpha-pinene in man after exposure by inhalation.

    FavorávelEnsaio ClínicoAsmaTosse
  248. 1987

    Effect of a Secretolytic and a Combination of Pinene, Limonene and Cineole on Mucociliary Clearance in Patients With Chronic Obstructive Pulmonary Disease

    FavorávelEnsaio ClínicoDPOC
  249. 1983

    Comparison Of Bronchial Effects Of Nabilone And Terbutaline In Healthy And Asthmatic Subjects

    InconclusivoEnsaio Clínico Duplo-CegoAsmaTHC Farmacêutico
  250. 1981

    [Pharmacological studies with an ointment containing menthol, camphene and essential oils for broncholytic and secretolytic effects]

    FavorávelEstudo LaboratorialInfecções BacterianasDPOCBronquite+1
  251. 1978

    Bronchodilator Effect Of Delta1-tetrahydrocannabinol

    FavorávelEnsaio ClínicoAsma
  252. 1977

    Bronchial Effects Of Aerosolized Delta 9-tetrahydrocannabinol In Healthy And Asthmatic Subjects

    FavorávelEnsaio Clínico Duplo-CegoAsmaIncontinência UrináriaTetraidrocanabinol (THC)
  253. 1976

    Antitussive activity of some naturally occurring cannabinoids in anesthetized cats.

    FavorávelEstudo em AnimaisTosseTetraidrocanabinol (THC)Canabinol (CBN)
  254. 1976

    Bronchodilator Effect Of Delta1-tetrahydrocannabinol Administered By Aerosol Of Asthmatic Patients

    FavorávelEnsaio Clínico Duplo-CegoAsma
  255. 1975

    Antineoplastic Activity Of Cannabinoids

  256. 1975

    Effects Of Smoked Marijuana In Experimentally Induced Asthma

    FavorávelEnsaio Clínico Duplo-CegoAsmaTetraidrocanabinol (THC)
  257. 1974

    A pilot study of orally administered Δ1-trans-tetrahydrocannabinol in the management of patients undergoing radiotherapy for carcinoma of the bronchus

    FavorávelEnsaio ClínicoCâncerCâncer — PulmãoTHC Farmacêutico
  258. 1974

    Acute Effects of Smoked Marijuana and Oral Δ9-Tetrahydrocannabinol on Specific Airway Conductance in Asthmatic Subjects

    FavorávelEnsaio Clínico Duplo-CegoAsmaTetraidrocanabinol (THC)
  259. 1973

    Anti-Edema And Analgesic Properties of Δ9-Tetrahydrocannabinol (THC)

    FavorávelEstudo em AnimaisEdemaTetraidrocanabinol (THC)
  260. 1970

    Marihuana Bronchitis

    InconclusivoMetanáliseBronquite
  261. 1960

    Cannabis as a medicament.

    FavorávelEstudo LaboratorialTuberculose

Continue por aqui

Perguntas frequentes

Quantos estudos sobre sistema respiratório estão indexados no acervo?
São 261 estudos, publicados entre 1960 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 124 · Estudo Laboratorial: 59 · Estudo em Animais: 44 · Ensaio Clínico Duplo-Cego: 18 · Ensaio Clínico: 16. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 170 favoráveis, 41 inconclusivos e 50 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Sistema Respiratório — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/sistema/sistema-respiratorio/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Sistema Respiratório — estudos científicos sobre cannabis. https://cannabisindica.com.br/sistema/sistema-respiratorio/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.